Nov 01 2008
Goverment: FDA Faulted for Stance on Chemical in Plastics
FDA Faulted for Stance on Chemical in Plastics – washingtonpost.com
The FDA’s position on BPA has been controversial because it contradicted more than 100 studies, as well as a finding by the U.S. National Toxicology Program, that there was “some concern” that BPA may affect the brain and behavioral development in fetuses, infants and small children, thePostsaid.
Relying on the government for protection puts us at risk. It invariably becomes politicized. As the quote above points out, the FDA (your watchdog!) approved something more than a hundred studies said was a bad idea.
Private consumer protection is a better option. The FDA has no profits at stake when their advice is wrong, and there is no one to watch the watchdog when that watchdog is the government.
